Aandelen in “Diensten aan de gezondheidssector”

Aandeel Datum Koers Evolutie
Geen effecten gevonden.

Nieuws over “Diensten aan de gezondheidssector”

14:00 · Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com · Persbericht

14:00 · Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com · Persbericht

14:00 · Frontier AI models score worse than a coin flip on grammar in some languages, according to TrainAI · Persbericht

24/08 · Mynd.ai Unveils Privacy-First AI Tools to Improve Engagement in Classrooms and Workplaces · Persbericht

24/08 · Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference · Persbericht

24/08 · Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology · Persbericht

24/08 · Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings · Persbericht

18/08 · Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health · Persbericht

17/08 · MYND.AI, INC. RECEIVES NYSE AMERICAN APPROVAL OF COMPLIANCE PLAN AND EXTENSION THROUGH DECEMBER 2027 · Persbericht

17/08 · Labcorp to Host Investor Day on September 10, 2026 · Persbericht

12/08 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

10/08 · Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma · Persbericht

4/08 · Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer · Persbericht

3/08 · RWS reaches agreement to acquire Acolad · Persbericht

30/07 · Strong H1 2026 business performance: H1 revenue of €124.5 million (+7.3% on a reported basis) and ARR of €111.1 million at 30 June 2026 (+8.8% vs. 30 June 2025) · Persbericht

30/07 · Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics · Persbericht

30/07 · Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance · Persbericht

27/07 · Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing · Persbericht

23/07 · Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 · Persbericht

14/07 · RWS launches new linguistic validation service to significantly reduce clinical trial timelines · Persbericht

10/07 · One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns · Persbericht

Mijn selecties